Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study

CONTEXT: Glucocorticoid excess exhibits multiple detrimental effects by its catabolic properties. Metformin was recently suggested to protect from adverse metabolic side-effects of glucocorticoid treatment. Whether metformin is beneficial in patients with endogenous glucocorticoid excess has not bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogel, Frederick, Braun, Leah, Rubinstein, German, Zopp, Stephanie, Oßwald, Andrea, Schilbach, Katharina, Schmidmaier, Ralf, Bidlingmaier, Martin, Reincke, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578886/
https://www.ncbi.nlm.nih.gov/pubmed/34777259
http://dx.doi.org/10.3389/fendo.2021.765067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578886/
https://www.ncbi.nlm.nih.gov/pubmed/34777259
http://dx.doi.org/10.3389/fendo.2021.765067

Ejemplares similares